Tamara Mihic
Overview
Explore the profile of Tamara Mihic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gessner B, Carter M, Rahnama K, Almeida A, Borralho C, Mihic T, et al.
Ment Health Clin
. 2024 May;
14(2):85-91.
PMID: 38694883
Introduction: Clozapine is the most effective antipsychotic in the management of treatment-resistant schizophrenia; however, its use is challenging due to the risk of severe adverse effects. Despite the risks associated...
2.
Jennifer Wong Y, Mihic T, Wan A, Fan J, Gnyra M
J Clin Psychopharmacol
. 2023 Dec;
44(1):73-74.
PMID: 38100785
No abstract available.
3.
Jennifer Wong Y, Fan J, Wan A, Mihic T, Gnyra M
J Clin Psychopharmacol
. 2023 May;
43(3):283-294.
PMID: 37126830
Background: Hyperammonemia is an adverse effect that poses clinical uncertainty around valproic acid (VPA) use. The prevalence of symptomatic and asymptomatic hyperammonemia and its relationship to VPA concentration is not...
4.
Ti L, Mihic T, James H, Shalansky S, Legal M, Nolan S
Can J Hosp Pharm
. 2022 Apr;
75(2):113-117.
PMID: 35387376
No abstract available.
5.
Xu K, Nolan S, Mihic T, Ti L
J Am Pharm Assoc (2003)
. 2022 Feb;
62(3):697-700.
PMID: 35221235
Opioid stewardship has emerged as an innovative systems-level approach designed to reduce inappropriate opioid prescriptions and improve patient safety in acute care settings. Modeled on the successes of antimicrobial stewardship...
6.
Poteryko S, Nolan S, Mihic T, Ti L
J Addict Med
. 2021 Oct;
16(4):386-388.
PMID: 34690337
The opioid-driven overdose crisis has had devastating effects across North America, resulting from a complex interplay between individual, social-structural, and environmental factors. Changing approaches to pain management, increased heroin use,...
7.
Chen A, Legal M, Shalansky S, Mihic T, Su V
Can J Hosp Pharm
. 2021 Jul;
74(3):248-255.
PMID: 34248165
Background: Deaths due to overdose from illicit drugs have risen in Canada, despite various community-led harm reduction programs. There have been limited pharmacist-led inpatient initiatives aimed at reducing opioid harm....
8.
Woods B, Legal M, Shalansky S, Mihic T, Ma W
Can J Hosp Pharm
. 2020 Feb;
73(1):7-12.
PMID: 32109955
Background: Despite the recent increase in opioid overdoses across Canada, few pharmacy-led initiatives have been implemented to address issues related to opioid prescribing in the hospital setting. Objectives: The primary...
9.
Higgins J, San C, Lagnado G, Chua D, Mihic T
Can J Psychiatry
. 2019 Jan;
64(8):561-567.
PMID: 30599763
Objective: Clozapine, an antipsychotic reserved for management of treatment-resistant schizophrenia, is associated with severe adverse effects, including myocarditis. This study aims to determine the incidence of clozapine-induced myocarditis at a...
10.
Wang J, Mihic T, Fennemore M
Psychosomatics
. 2018 Sep;
60(3):328-330.
PMID: 30181003
No abstract available.